Glaucoma is a group of eye conditions that damage the optic nerve, which is crucial for good vision. This damage is often caused by abnormally high pressure in your eye. It is one of the leading ...
Glaucoma is the second most common cause of blindness in the United States and worldwide. [1,2] It is a progressive optic neuropathy characterized by nerve atrophy and loss of retinal ganglion cells.
Increased intraocular pressure (IOP) represents a major risk factor for glaucoma, a prevalent eye disease characterized by death of retinal ganglion cells; lowering IOP is the only proven treatment ...
Researchers at the Center for Vascular Research, within the Institute for Basic Science (IBS), have identified a new mechanism involved in the development and progression of glaucoma, and found a ...
Gel-like fluids inside the eye help it maintain its shape, which plays an important role in overall eye health. These substances are called the vitreous humor and aqueous humor. Vitreous is a ...
A rise in IOP will be compensated by an increased rate of aqueous humor drainage through the trabecular meshwork and uveoscleral routes. [18] The bulk of aqueous humor drainage occurs through the ...
Jason Yosar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Glaucoma typically occurs when a blockage in the eye's drainage channels causes aqueous humor fluid to accumulate within the eye faster than it can drain out. This increases intraocular pressure, ...
Omlonti is a relatively selective EP2 receptor agonist designed to increase aqueous humor drainage through the conventional (or trabecular) and uveoscleral outflow pathways. The Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback